findmyKOL
Clinical trialNCT01116427CompletedPhase 2Interventional

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment65Multiple Sclerosis, Relapsing-Remitting
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Ottawa Hospital Research Institute

    Ottawa, Ontario, Canada

United States
  • St. Josephs Hospital and Medical Center - Barrow Neurology

    Phonix, Arizona, United States

  • Jordan Research and Education Institute (redi): Alta Bates Summit Medical Center

    Berkeley, California, United States

  • University of Southern California - Keck School of Medicine

    Los Angeles, California, United States

  • Newport Beach Clinical Research Associates, Inc.

    Newport Beach, California, United States

  • University of California, Davis

    Sacramento, California, United States

  • University of Miami

    Miami, Florida, United States

  • South Suburban Neurology

    Flossmoor, Illinois, United States

  • Norton Neuroscience Institute - Norton Neurology Services Ms Center

    Louisville, Kentucky, United States

  • Louisiana State University

    Shreveport, Louisiana, United States

  • University of Maryland

    Baltimore, Maryland, United States

  • Brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Judith Jaffe Multiple Sclerosis Center: Weill Cornell Medical College

    New York, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • Neurology Specialists, Inc.

    Dayton, Ohio, United States

  • Providence St. Vincent Medical Center

    Portland, Oregon, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • the Neurology Foundation, Inc.

    Providence, Rhode Island, United States

  • Advanced Neurosciences Institute

    Franklin, Tennessee, United States

  • Benaroya Research Institute at Virginia Mason

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2010
Primary completion
30 Jun 2014
Completion
28 Feb 2015
Last update posted
15 Sept 2016
Registered enrollment
65
Registry id
NCT01116427

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.